Matthew L. Faron
- Clinical Biochemistry top 1%
- Bacterial Identification and Susceptibility Testing 16
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria 6
- Infectious Diseases top 5%
- Viral gastroenteritis research and epidemiology 5
- SARS-CoV-2 detection and testing 5
- SARS-CoV-2 and COVID-19 Research 4
- Endocrinology top 5%
-
- Streptococcal Infections and Treatments 9
-
- Infective Endocarditis Diagnosis and Management 7
- Respiratory viral infections research 4
- Co-authors
- Nathan A. LedeboerBlake W. BuchanBradley D. JonesJoshua R. FletcherJed A. RasmussenL. Silvia Muñoz-PriceA JanszGeneviève Soucy
- Journals
- Journal of Clinical Microbiology (21 papers)Diagnostic Microbiology and Infectious Disease (3 papers)American Journal of Clinical Pathology (3 papers)
- Partner nations
- United StatesCanadaNetherlands
In The Last Decade
Matthew L. Faron
41 papers receiving 819 citations
Peers
Comparison fields: 5 of 91
- Clinical Biochemistry 348
- Molecular Medicine 130
- Infectious Diseases 318
- Endocrinology 81
- Applied Microbiology and Biotechnology 29
Countries citing papers authored by Matthew L. Faron
This map shows the geographic impact of Matthew L. Faron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew L. Faron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew L. Faron more than expected).
Fields of papers citing papers by Matthew L. Faron
This network shows the impact of papers produced by Matthew L. Faron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew L. Faron. The network helps show where Matthew L. Faron may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Matthew L. Faron, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 2 | |
| 3 | 2023 | 2 | |
| 4 | 2021 | 1 | |
| 5 | 2020 | 48 | |
| 6 | 2020 | 21 | |
| 7 | 2019 | 6 | |
| 8 | 2019 | 26 | |
| 9 | 2019 | 23 | |
| 10 | 2019 | 0 | |
| 11 | 2017 | 6 | |
| 12 | 2017 | 82 | |
| 13 | 2017 | 2 | |
| 14 | 2016 | 5 | |
| 15 | 2016 | 38 | |
| 16 | 2016 | 144 | |
| 17 | 2016 | 5 | |
| 18 | 2015 | 12 | |
| 19 | 2015 | 31 | |
| 20 | 2015 | 45 |
About Matthew L. Faron
Matthew L. Faron is a scholar working on Clinical Biochemistry, Molecular Medicine and Infectious Diseases, having authored 44 papers that have together received 838 indexed citations. Recurring topics across this work include Bacterial Identification and Susceptibility Testing (16 papers), Streptococcal Infections and Treatments (9 papers), Infective Endocarditis Diagnosis and Management (7 papers), Antibiotic Resistance in Bacteria (6 papers), Viral gastroenteritis research and epidemiology (5 papers), SARS-CoV-2 detection and testing (5 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and Respiratory viral infections research (4 papers). The work is most often cited by research in Clinical Biochemistry (348 citations), Molecular Medicine (130 citations) and Infectious Diseases (318 citations). Matthew L. Faron has collaborated with scholars based in United States, Canada and Netherlands. Frequent co-authors include Nathan A. Ledeboer, Blake W. Buchan, Bradley D. Jones, Joshua R. Fletcher, Jed A. Rasmussen, L. Silvia Muñoz-Price, A Jansz, Geneviève Soucy, Donna Mayne and Cameron G. Gmehlin. Their work appears in journals such as Journal of Clinical Microbiology, Diagnostic Microbiology and Infectious Disease, American Journal of Clinical Pathology, PLoS ONE and Infection and Immunity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.